Table 1 A two-way table is used to compare proportions of the final number of poor responders, non responders and responders after treatment with aflibercept (AFL) in the ranibizumab (RBZ) non responder and poor responder groups
AFL non-responder group | AFL poor-responder group | AFL responder group | Total | |
|---|---|---|---|---|
RBZ non-responder group | 9 | 14 | 22 | 45 |
RBZ poor-responder group | 6 | 2 | 3 | 11 |
Total | 15 | 16 | 25 | 56 |